Become part of our test community

Are you interested in testing the usability of medical apps and new developments of products for self-medication? Then register for the Ypsomed test community!

Injection systems for self-medication

Delivery Systems

Ypsomed Delivery Systems (YDS) provides a complete range of technologies and services for reliable and user-friendly injection systems for self-medication. Our customers are pharmaceutical and biotechnology companies that develop, manufacture and market injectable therapies.

We offer:

Modular and proven platform technologies
Comprehensive services tailored to our customers requirements
A full range of in-house manufacturing capabilities
Explore Ypsomed Delivery Systems


8 Mio. people use our solutions.

100 % electricity from renewable energy sources.

9 platforms foster economies of scale and enable a fast customisation.

392 in-house employees in research and development.

News and stories

Ypsomed's Earth Day Commitment


On Earth Day we stand united in our dedication to sustainability. We take responsibility for the environmental, social and societal impact of our actions and strive for long-term and sustainable development – ready to make a difference.


Solutions for people with diabetes mellitus


With its mylife Diabetescare brand, Ypsomed offers a comprehensive portfolio of products and services for people with diabetes. This allows users easy, discreet and reliable self-treatment. With mylife Diabetescare, self-treatment becomes simpler and easier.

We offer:

Infusion Systems
Blood glucose monitoring systems
Therapy management
Pen needles
Explore Ypsomed Diabetes Care

News and stories

Would you like to get to know us better? Read our exciting stories and find out more about the world of Ypsomed.

Jobs and Careers

Time for a new challenge? Our jobs offer interesting opportunities for your development and career.

Delivery Systems Newsletter

Are you interested in receiving the latest industry, product and development news from Ypsomed Delivery Systems? Just subscribe to our newsletter.